Amoy Diagnostics (300685.SZ) Market Update: Flat Trading, 13.8% Decline & Q3 2026 Results
Amoy Diagnostics shares traded flat amid a 13.8% month‑over‑month decline, yet Q3 2026 results show improved cash flow and earnings per share, with key biotech partnerships and a share‑transfer agreement boosting investor confidence.
- AMOY DIAGNOSTICS CO LTD
- China
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read